Skip to main content

Table 4 Continued acceptance of treatment in view of information on potential side effects

From: Determinants for acceptance of preventive treatment against heart disease – a web-based population survey

  Continue to accept treatment despite side effects*
  Accepting, n (%) ORcrude ORadj** (95%-CI) Test for trend
Total 156 (42.7) - - -
Gender    p = 0.889 p = 0.832  
 Male 84 (43.1) (ref) (ref) -
 Female 72 (42.4) 0.97 0.95 (0.62, 1.47)  
Age groups    p = 0.205 p = 0.257  
 40-44 18 (34.6) (ref) (ref) pcrude = 0.838
 45-49 47 (51.7) 2.02 1.96 (0.96, 4.03) padj = 0.960
 50-54 37 (41.1) 1.32 1.23 (0.60, 2.54)  
 55-60 54 (40.9) 1.31 1.38 (0.70, 2.74)  
Health status    p = 0.804 p = 0.682  
 Good/very good 95 (44.0) (ref) (ref) pcrude = 0.577
 Fair 48 (40.3) 0.86 0.97 (0.43, 2.22) padj = 0.458
 Poor/very poor 12 (41.4) 0.90 1.24 (0.59, 2.58)  
Experience with heart disease    p = 0.656 p = 0.609 -
 Yes, have or have had myself 14 (40.0) (ref) (ref)  
 Yes, family member has had 34 (39.1) 0.96 0.81 (0.50, 1.31)  
 No 103 (44.4) 1.20 0.86 (0.38, 1.97)  
Price    p = 0.402 p = 0.401  
 DKK 100 69 (45.7) (ref) (ref) pcrude = 0.725
 DKK 400 43 (37.7) 0.72 0.71 (0.43, 1.18) padj = 0.705
 DKK 700 44 (44.4) 0.95 0.94 (0.56, 1.59)  
  1. *Among the 365 (34.1%) subjects who originally accepted treatment.
  2. **Adjusted for gender, age (four groups), experience with heart disease, price.